While CMS proposes a 12- and 36-month reconciliation period in the Medicare Part D Drug Inflation Rebate Program, due largely to the 36-month restatement period provided for MDRP AMP restatements (specified in 447.510(d)(3)), CMS does not believe a second or longer restatement process is needed for Part B rebatable drugs because, as described previously, the ASP and claims run-out periods correspond with sufficient claims run-out and ASP restatement timing for Part B (particularly when considering penalties associated with failure to submit timely and accurate ASP data (specified in 414.806(b))
Global burden of tobacco use
A rich and creamy texture of Vanilla, Caramel, and Honey is applied to Burley, Virginia, and Black Cavendish
Archived from the original (PDF) on April 29, 2017
Public Health Service Publication No
10.1016/j.tiv.2015.08.004 72